Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-47906 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- PPP1R8 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- This antibody detects human, mouse, and rat NIPP1 in Western blots and recombinant human NIPP1 in direct ELISAs. Reconstitute in sterile PBS to a final concentration of 0.2 mg/mL.
- Reactivity
- Human, Mouse, Rat
- Host
- Sheep
- Isotype
- IgG
- Vial size
- 100 µg
- Concentration
- 0.2 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis from lysates of Saos-2 human osteosarcoma cell line, Jurkat human acute T cell leukemia cell line, M1 mouse myeloid leukemia cell line, NRK rat normal kidney cell line, and NR8383 rat alveolar macrophage cell line. PVDF membrane was probed with 0.5 µg/mL of Sheep Anti-human/mouse/Rat NIPP1 Antigen Affinity-purified Polyclonal Antibody (Product # PA5-47906) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody. A specific band was detected for NIPP1 at approximately 40 kDa (as indicated). This experiment was conducted under reducing conditions.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of PPP1R8 in Saos‚2 human osteosarcoma cell line, Jurkat human acute T cell leukemia cell line, M1 mouse myeloid leukemia cell line, NRK rat normal kidney cell line, and NR8383 rat alveolar macrophage cell line. Samples were incubated in PPP1R8 polyclonal antibody (Product # PA5-47906) using a dilution of 0.5 µg/mL followed by a HRP-conjugated Anti-Sheep IgG secondary antibody. A specific band was detected for NIPP1 at approximately 40 kDa (as indicated). This experiment was conducted under reducing conditions.